Disease Severity and Quality of Life in Patients With IPF

In this podcast, Emily O'Brien, PhD, answers our questions about the objective measures of disease severity that affect quality of life among patients with idiopathic pulmonary fibrosis, how these findings impact clinical practice, and the knowledge gaps that still exist.

Additional Resource:

  • O’Brien EC, Hellkamp AS, Neely ML, et al; IPF-PRO Registry Investigators. Disease severity and quality of life in patients with idiopathic pulmonary fibrosis: a cross-sectional analysis of the IPF-PRO Registry [January 15, 2020]. CHEST. https://doi.org/10.1016/j.chest.2019.11.042.  

Emily O’Brien, PhD, is an assistant professor in population health sciences at Duke University School of Medicine and an epidemiologist and health services researcher at the Duke Clinical Research Institute at Duke University in Durham, North Carolina.

Submit Feedback

Name